January 2017• Volume 124• Number 1 www. anesthesia-analgesia. org 217 (i) to identify,
evaluate, and manage anemia;(ii) reduce iatrogenic blood loss;(iii) optimize hemostasis; …

Optimal dose, timing and ratio to red blood cells (RBC) of blood component therapy (fresh
frozen plasma [FFP], platelets, cryoprecipitate or fibrinogen concentrate) to reduce morbidity …

Patient blood management (PBM) is the timely application of evidence-informed medical
and surgical concepts designed to maintain haemoglobin concentration, optimise …

Background: Postpartum haemorrhage (PPH) can be exacerbated by haemostatic failure.
We hypothesized that early fibrinogen replacement, guided by viscoelastometric testing …

Postpartum haemorrhage (PPH) is caused by obstetric complications but may be
exacerbated by haemostatic impairment. In a 10-year programme of research we have …

Background Postpartum haemorrhage (PPH)‐heaving bleeding within the first 24 hours after
giving birth‐is one of the main causes of death of women after childbirth. Antifibrinolytics …

Background. Postpartum haemorrhage (PPH) can be exacerbated by haemostatic failure.
Based on data from trauma studies, empirical infusions of fresh frozen plasma (FFP) are …

Massive obstetric hemorrhage is a major cause of maternal mortality and morbidity
worldwide. It is defined (among others) as the loss of> 2500 ml of blood, and is associated to …

This research was carried out between June 2012 and August 2013, where I was employed
as a research fellow at the Department of Anaesthesiology and Intensive Care Medicine …

Obstetric hemorrhage remains a leading cause of maternal morbidity and mortality
worldwide. Many postpartum hemorrhages (PPHs) do not have identifiable risk factors; …